HIGHLIGHTS
- who: Davorka Repac Antić et al. from the Department of Microbiology and Parasitology, Faculty of Medicine, University of, , Bonn, Germany have published the research: Chelation in Antibacterial Drugs: From Nitroxoline to Cefiderocol and Beyond, in the Journal: Antibiotics 2022, 11, 1105. of /2022/
- what: The authors show the impressive spectrum of roles that chelation plays in antibacterial MOAs. In this review, the authors explore and present the ways that chelation is involved in MOAs of a wide scope of antibacterial drugs, class by class, from a century-old nitroxoline to new cefiderocol and potentially new . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.